Coexpression of hepatocyte growth factor and c-Met proto-oncogene product in synovial sarcoma

Pathology International

Volumn 48, Issue 10, 1998, Pages 769-775

  Motoi, Toru ^a   Ishida, Tsuyoshi ^a   Kuroda, Masahiko ^a   Horiuchi, Hajime ^a   Oka, Teruaki ^a   Matsumoto, Kunio ^b   Nakamura, Toshikazu ^b   Machinami, Rikuo ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

Author keywords

C Met proto oncogene; Hepatocyte growth factor; Immunohistochemistry; Synovial sarcoma

Indexed keywords

CYTOKERATIN; EPITHELIAL MEMBRANE ANTIGEN; ONCOPROTEIN; SCATTER FACTOR; VIMENTIN;

ADOLESCENT; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SPINDLE CELL; SYNOVIAL SARCOMA;

EID: 0031718410     PISSN: 13205463     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1827.1998.tb03836.x     Document Type: Article

References (39)

1. Enzinger FM, Weiss SW, eds. Soft Tissue Tumors, 3rd edn. Mosby-Year Book Inc., St Louis, 1995.
2. Evans HL. Synovial sarcoma: A study of 23 Diphasic and 17 probable monophasic examples (review). Pathol. Annu. 1980; 15: 309-331.
3. Fisher C. Synovial sarcoma: Ultrastructural and immunohistochemical features of epithelial differentiation in monophasic and biphasic tumors. Hum. Pathol. 1986; 17: 996-1008.
4. Mickelson MR, Brown GA, Maynard JA, Cooper RR, Bonfiglio M. Synovial sarcoma: An electron microscopic study of monophasic and biphasic forms. Cancer 1980; 45: 2109-2118.
5. Miettinen M, Lehto VP, Virtanen I. Keratin in the epithelial-like cells of classical biphasic synovial sarcoma. Virchows Arch. B Cell Pathol. 1982; 40: 157-161.
6. Ordonez NG, Mahfouz SM, Mackay B. Synovial sarcoma: An immunohistochemical and ultrastructural study. Hum. Pathol. 1990; 21: 733-749.
7. Dardick I, Ramjohn S, Thomas MJ, Jeans D, Hammar SP. Synovial sarcoma: Inter-relationship of the biphasic and monophasic subtypes. Pathol. Res. Pract. 1991; 187: 871-885.
8. Ghadially FN. Is synovial sarcoma a carcinosarcoma of connective tissue? Ultrastruct. Pathol. 1987; 11: 147-151.
9. Miettinen M, Virtanen I. Synovial sarcoma: A misnomer. Am. J. Pathol. 1984; 117: 18-25.
10. Sandberg AA, Bridge JA, eds. The Cytogenetics of Bone and Soft Tissue Tumors, 1st edn. RG Landes Company, Georgetown, 1994.
11. Clark J, Rocques PJ, Crew AJ et al. Identification of novel genes, SYT and SSX, involved in the t (X;18) (p11.2;q11.2) translocation found in human synovial sarcoma. Nat. Genet. 1994; 7: 502-508.
12. Fligman I, Lonardo F, Jhanwar SC, Gerald WL, Woodruff J, Ladanyi M. Molecular diagnosis of synovial sarcoma and characterization of a variant SYT-SSX2 fusion transcripts. Am. J. Pathol. 1995; 147: 1592-1599.
13. Kashima T, Matsushita H, Kuroda M et al. Biphasic synovial sarcoma of the peritoneal cavity with t (X;18) demonstrated by reverse transcriptase polymerase chain reaction. Pathol. Int. 1997;47:637-641.
14. Stoker M, Gherardi E, Perryman M, Gray J. Scatter factor is a fibroblast-derived modulator of epithelial cell mobility. Nature 1987;327:239-242.
15. Nakamura T, Teramoto H, Ichihara A. Partial purification and characterization of hepatocyte growth factor from serum of hepatectomized rats. Biochem. Biophys. Res. Commun. 1984; 122: 1450-1459.
16. Nakamura T, Nawa K, Ichihara A, Kaise N, Nishio T. Purification and subunit structure of hepatocyte growth factor from rat platelets. FEBS Lett. 1987; 224: 311-316.
17. Matsumoto K, Nakamura T. Pleiotropic roles of HGF in mitogenesis, morphogenesis, and organ regeneration. In: Nakamura T, Matsumoto K, eds. Monograph on Cancer Research, Vol. 42. Japan Scientific Societies Press CRC Press, Tokyo, 1994; 99-112.
18. Tajima H, Matsumoto K, Nakamura T. Hepatocyte growth factor has potent anti-proliferative activity in various tumor cell lines. FEBS Lett. 1991; 291: 229-232.
19. Montesano R, Matsumoto K, Nakamura T, Orchi L. Identification of a fibroblast-derived epithelial morphogen as hepatocyte growth factor. Cell 1991; 67: 901-908.
20. Tsarfaty I, Resau JH, Rulong S, Keydar I, Faletto DL, Vande Woude GF. The met proto-oncogene receptor and lumen formation. Science 1992; 257: 1258-1261.
21. Bottaro DP, Rubin JS, Faletto DL et al. Identification of the hepatocyte growth factor receptor as the c-met proto-oncogene product. Science 1991; 251: 802-804.
22. Park M, Dean M, Kaul K et al. Sequence of MET protooncogene cDNA has features characteristic of the tyrosine kinase family of growth-factor receptors. Proc. Natl Acad. Sci. USA 1987; 84: 6379-6383.
23. Cooper CS, Park M, Blair DG et al. Molecular cloning of a new transforming gene from a chemically transformed human cell line. Nature 1984; 311: 29-33.
24. Gherardi E, Gray J, Stoker M, Perryman M, Furlong R. Purification of scatter factor, a fibroblast-derived basic protein that modulates epithelial interactions and movement. Proc. Natl Acad. Sci. USA 1989; 86: 5844-5848.
25. Rosen EM, Grant D, Kleiman H et al. Scatter factor stimulates migration of vascular endothelium and capillary-like tube formation (Review). EXS 1991; 59: 76-88.
26. Sonnenberg E, Meyer D, Weidner KM, Birchmeier C. Scatter factor/hepatocyte growth factor and its receptor, the c-met tyrosine kinase, can mediate a signal exchange between mesenchyme and epithelia during mouse development. J. Cell Biol. 1993; 123: 223-235.
27. Ishiki Y, Ohnishi H, Muto Y, Matsumoto K, Nakamura T. Direct evidence that hepatocyte growth factor is a hepatotrophic factor for liver regeneration and has a potent antihepatitis effect in vivo. Hepatology 1992; 16: 1227-1235.
28. Igawa T, Matsumoto K, Kanda S, Saito Y, Nakamura T. Hepatocyte growth factor may function as a renotropic factor for regeneration in rats with acute renal injury. Am. J. Physiol. 1993; 265: F61-F69.
29. Yanagita K, Matsumoto K, Sekiguchi K, Ishibashi H, Niho Y, Nakamura T. Hepatocyte growth factor may act as a pulmotrophic factor on lung regeneration after acute lung injury. J. Biol. Chem. 1993; 268: 21212-21217.
30. Ishida T, Kojima T, Iijima T et al. Synovial sarcoma with a predominant epithelial component. Int. J. Surg. Pathol. 1994; 1: 261-268.
31. Yoshinaga Y, Matsuno Y, Fujita S et al. Immunohistochemical detection of hepatocyte growth factor/scatter factor in human cancerous and inflammatory lesions of various organs. Jpn. J. Cancer Res. 1993; 84: 1150-1158.
32. Jennische E, Ekberg S, Matejka GL. Expression of hepatocyte growth factor in growing and regenerating rat skeletal muscle. Am. J. Physiol. 1993; 265: C122-C128.
33. Yanagita K, Nagaike M, Ishibashi H, Niho Y, Matsumoto K, Nakamura T. Lung may have an endocrine function producing hepatocyte growth factor in response to injury of distal organs. Biochem. Biophys. Res. Commun. 1992; 182: 802-809.
34. Ferracini R, Di Renzo MF, Scotlandi K et al. The Met/HGF receptor is over-expressed in human osteosarcomas and is activated by either a paracrine or an autocrine circuit. Oncogene 1995; 10: 739-749.
35. Rong S, Jeffers M, Resau JH, Tsarfaty I, Oskarsson M, Vande Woude GF. Met expression and sarcoma tumorigenicity. Cancer Res. 1993; 53: 5355-5360.
36. Berdichevsky F, Alfred D, D'souza B, Taylor-Papadinitriou J. Branching morphogenesis of human mammary epithelial cells in collagen gels. J. Cell Sci. 1994; 107: 3357-3368.
37. Tsarfaty I, Rong S, Resau JH, Rulong S, da Silva PP, Vande Woude GF. The Met proto-oncogene mesenchymal to epithelial cell conversion. Science 1994; 263: 98-101.
38. Kawai A, Woodruff J, Healey JH, Brennan MF, Antoneseu CR, Ladanyi M. SYT-SSX gene fusion as a determinant of morphology and prognosis in synovial sarcoma. N. Engl. J. Med. 1998; 338: 153-160.
39. Mizuno K, Inoue H, Hagiya M et al. Hairpin loop and second kringle domain are essential sites for heparin binding and biological activity of hepatocyte growth factor. J. Biol. Chem. 1994; 269: 1131-1136.